从内分泌病变到组织细胞疾病诊断的临床路径
组织细胞肿瘤常以内分泌病变为首发表现,朗格汉斯细胞组织细胞增生症和Erdheim-Chester病可浸润下丘脑和/或垂体,导致精氨酸加压素缺乏(AVP-D)和前叶垂体功能障碍(APD),发生率为20%至30%。本文概述其内分泌表现并提供简化诊断流程,指导对「特发性」AVP-D或APD病例进行影像学和活检评估。
要点
- 组织细胞肿瘤常以内分泌病变为首发表现,AVP-D和APD发生率为20%至30%。
- 组织细胞疾病占所有垂体柄病变的10%至15%。
- 对「特发性」AVP-D或APD应进行影像学检查和疑似病灶活检以排查组织细胞肿瘤。
核心结论
- 内分泌病变常是组织细胞肿瘤的首发表现,内分泌科医生处于早期诊断的前线。
- 组织细胞肿瘤治疗高效,但内分泌病变被认为是永久性的,需要长期激素替代。
- 早期诊断和新型靶向治疗能否逆转这些内分泌病变仍不清楚。
研究设计与样本
- 本文为临床路径综述,概述组织细胞疾病的内分泌表现并提供简化诊断流程。
主要发现
- 朗格汉斯细胞组织细胞增生症和Erdheim-Chester病可浸润下丘脑和/或垂体,导致AVP-D和APD,发生率为20%至30%,常作为首发表现。
- 组织细胞疾病占所有垂体柄病变的10%至15%。
- 此类病例中组织细胞增生症的诊断常因内分泌病变和垂体受累的非特异性表现而延迟。
关键数值与推荐
- 对表现为「特发性」AVP-D或APD的病例,应通过额外影像学检查和疑似病灶活检评估组织细胞肿瘤。
- 若未发现垂体以外的病灶,必须仔细权衡垂体柄病变活检的风险与获益。
临床怎么用
- 内分泌科医生应识别这些疾病的多种非内分泌特征以实现早期诊断。
- 对「特发性」AVP-D或APD病例应评估组织细胞肿瘤,行额外影像学检查和疑似病灶活检。
- 若无垂体以外病灶,垂体柄病变活检的风险与获益须仔细考虑。
局限性
- 早期诊断和新型靶向治疗能否逆转这些内分泌病变仍不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endocrinopathies are frequently the initial presentation of histiocytic neoplasms, which are rare hematologic disorders affecting multiple organ systems. Langerhans cell histiocytosis and Erdheim-Chester disease are 2 such disorders known to infiltrate the hypothalamus and/or pituitary gland, leading to arginine vasopressin deficiency (AVP-D) and anterior pituitary dysfunction (APD) in 20% to 30% of cases, often as the first manifestation. Conversely, histiocytic disorders account for a notable proportion (10-15%) of all pituitary stalk lesions. The diagnosis of histiocytoses is often delayed in such cases due to the nonspecific presentation of endocrinopathies and pituitary involvement. Consequently, endocrinologists are at the frontline and uniquely positioned to achieve early diagnosis by recognizing the varied nonendocrine features of these disorders. This article provides an overview of the endocrine manifestations of histiocytic disorders and presents a simplified algorithm to guide the diagnostic workup in cases presenting with "idiopathic" AVP-D or APD. Such cases should be evaluated for histiocytic neoplasms with additional imaging studies and biopsies of suspected disease sites. If no disease site beyond the pituitary is identified, the risks and benefits of a pituitary stalk lesion biopsy must be carefully considered. While treatments of histiocytic neoplasms are highly efficacious, endocrinopathies are considered permanent and require long-term hormone replacement. It remains unclear whether early diagnosis and novel targeted therapies can reverse these endocrine disorders. Therefore, the role of the endocrinologist role is critical in the diagnosis and management of these rare diseases.
引用
- Makras P, Erickson D, Davidge-Pitts CJ, et al. Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder. J Clin Endocrinol Metab. 2025. PMID: 39699236. doi:10.1210/clinem/dgae827
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。